<DOC>
	<DOCNO>NCT01486823</DOCNO>
	<brief_summary>This study healthy volunteer design investigate PK follow intravenous subcutaneous administration MLDL1278A ( also know BI-204 ) . The bioavalialbility MLDL1278A subcutaneous administration determine .</brief_summary>
	<brief_title>Bioavailability Study MLDL1278A After Subcutaneous Intravenous Administration Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Adult males/females age 18 55 year inclusive screening ; Subjects 18.0 30.0 kg/m2 body mass index ( BMI ) inclusive weigh 55.0 100.0 kg inclusive ; Any clinically relevant disease disorder ( past present ) , , opinion investigator , may either put subject risk participation study , influence result study , subject 's ability participate study ; Any clinically relevant abnormal finding physical examination , clinical chemistry , haematology , coagulation , urinalysis , vital sign ECG baseline , , opinion investigator , may put subject risk participation study ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>